You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Danoprevir Pharmacokinetic/Viral Kinetic Model for Treating Chronic HCV – Some Considerations

Antiviral Therapy

Impact Factor: 2.3 / 5-Year Impact Factor: 1.7

Journal Homepage Submission guidelines

Free access

Letter

First published online October, 2016

Danoprevir Pharmacokinetic/Viral Kinetic Model for Treating Chronic HCV – Some Considerations

Volume 21, Issue 7

https://doi.org/10.3851/IMP3046

Abstract

References

1.

Canini

L.

, Chatterjee

A.

, Guedj

J.

A pharmacokinetic/viral kinetic model to evaluate the treatment effectiveness of danoprevir against chronic HCV.

Antivir Ther 2015; 20: 469–477.

Browse journal

All articles Browse by year

Similar articles

Retricted access

Peripheral Nerve Myelin Modulates the Effect of Antidepressants on Major Histocompatibility Complex Expression on Macrophages in Experimental Allergic Neuritis

Retricted access

Agonist-Induced Release of Neuropeptide Y by Platelets

Retricted access

Anaphylaxis in Food Allergy

Retricted access

Neutrophils as Effectors of Host Defense and Host Damage. Physiopathology and Perspectives of Pharmacological Manipulation